(S)-2-Amino-3-(thiazol-4-yl)propanoic acid, 95.0%, 250mg

2-(2,5-dimethyl-1H-pyrrol-1-yl)ethanol, 95.0%, 250mg

3,5-Dimethoxybenzyl amine, 98.0%, 10g

Pinacol, 98.0%, 100g

2-Bromo-5-fluoro-3-nitrobenzoic acid, 95.0%, 1g

5-bromo-6-methoxy-4-methylpyridine-3-carbonitrile, 95.0%, 250mg

1-(4-Chlorophenyl)-2-methoxyethan-1-one, 95+%, 10g

3-Methylthiobenzamide, 98.0%, 5g

2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane>95.0%(GC)25g

2-Fluoro-6-(methylsulfanyl)benzoic acid, 97%, 1g

Microliter syringe GASTIGHT® series 1700 Point type 2, 50 µl, 1705 RN, 1 piece

6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine, 95%, 2.5g

1,1-DIFLUORO-6-AZASPIRO[2.5]OCTANE HCL, 95.0%, 1g